Literature DB >> 19355924

Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease.

R P W Rouhl1, R J van Oostenbrugge, J G M C Damoiseaux, L L Debrus-Palmans, R O M F I H Theunissen, I L H Knottnerus, J E A Staals, J R Delanghe, J W Cohen Tervaert, J Lodder.   

Abstract

Cerebral small vessel disease results in silent ischemic lesions (SIL) among which is leukoaraiosis. In this process, endothelial damage is probably involved. Endothelial progenitor cells (EPC), are involved in endothelial repair. By restoring the damaged endothelium, EPC could mitigate SIL and cerebral small vessel disease. Haptoglobin 1-1, one of three phenotypes of haptoglobin, relates to SIL and may therefore attenuate the endothelial repair by EPC. Our aim was to quantify EPC number and function and to assess haptoglobin phenotype and its effect on EPC function in patients with a high prevalence of SIL: lacunar stroke patients. We assessed EPC In 42 lacunar stroke patients and 18 controls by flow cytometry and culture with fetal calf serum, patient and control serum. We determined haptoglobin phenotype and cultured EPC with the three different haptoglobin phenotypes. We found that EPC cluster counts were lower in patients (96.9 clusters/well +/- 83.4 (mean +/- SD)), especially in those with SIL (85.0 +/- 64.3), than in controls (174.4 +/- 112.2). Cluster formation was inhibited by patient serum, especially by SIL patient serum, but not by control serum. Patients with haptoglobin 1-1 had less clusters in culture, and when haptoglobin 1-1 was added to EPC cultures, cluster numbers were lower than with the other haptoglobin phenotypes. We conclude that lacunar stroke patients, especially those with SIL, have impaired EPC cluster formation, which may point at decreased endothelial repair potential. The haptoglobin 1-1 phenotype is likely a causative factor in this impairment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355924     DOI: 10.2174/156720209787466082

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  14 in total

1.  Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Andrew Levy; Derek Leroith; Michal S Beeri
Journal:  Diabetologia       Date:  2015-01-28       Impact factor: 10.122

Review 2.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  Haptoglobin genotype and aneurysmal subarachnoid hemorrhage: Individual patient data analysis.

Authors:  Ben Gaastra; Dianxu Ren; Sheila Alexander; Ellen R Bennett; Dawn M Bielawski; Spiros L Blackburn; Mark K Borsody; Sylvain Doré; James Galea; Patrick Garland; Tian He; Koji Iihara; Yoichiro Kawamura; Jenna L Leclerc; James F Meschia; Michael A Pizzi; Rafael J Tamargo; Wuyang Yang; Paul A Nyquist; Diederik O Bulters; Ian Galea
Journal:  Neurology       Date:  2019-04-05       Impact factor: 9.910

4.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

5.  Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Authors:  Tina Costacou; Aaron M Secrest; Robert E Ferrell; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2014-07-03       Impact factor: 3.291

Review 6.  Endothelial cells and human cerebral small vessel disease.

Authors:  Atticus H Hainsworth; Asho T Oommen; Leslie R Bridges
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

7.  Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Elizabeth Guerrero-Berroa; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Andrew Levy; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  Diabetes Care       Date:  2013-08-29       Impact factor: 19.112

8.  Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors.

Authors:  Sheng-He Huang; Lin Wang; Feng Chi; Chun-Hua Wu; Hong Cao; Aimin Zhang; Ambrose Jong
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck Study.

Authors:  Raimund Pechlaner; Stefan Kiechl; Peter Willeit; Egon Demetz; Margot Haun; Siegfried Weger; Friedrich Oberhollenzer; Florian Kronenberg; Enzo Bonora; Günter Weiss; Johann Willeit
Journal:  J Am Heart Assoc       Date:  2014-05-16       Impact factor: 5.501

10.  The haptoglobin 1 allele correlates with white matter hyperintensities in middle-aged adults with type 1 diabetes.

Authors:  Tina Costacou; Caterina Rosano; Howard Aizenstein; Joseph M Mettenburg; Karen Nunley; Robert E Ferrell; Trevor J Orchard
Journal:  Diabetes       Date:  2014-09-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.